Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
BioMérieux Closes $416.8 Million Acquisition of Specific Diagnostics
Bringing the Specific Reveal Rapid AST system into the fold enhances French firm’s global position in clinical microbiology.
Delay in Submitting Genetic Tests Costs Life Sci Company $2.8 Million
In this Labs in Court Weekly Roundup, all the main health care-related cases involved False Claims Act allegations or charges.
Israeli Startup Salignostics Launches First Saliva-Based Pregnancy Test
The company has successfully completed clinical trials in Israel on more than 300 women and is applying for CE marking and FDA approval.
Minorities See Biggest Drops in Cancer Screening During the Pandemic
New research shows cancer screening prevalence declined in 2020 compared to 2018, though not for all cancer types studied.
FDA Warns of Cybersecurity Vulnerability in Certain NGS Instruments
A glitch in the local run management software may open the door to hacking, agency says.
Test-To-Treat Locations Now Up to 2,500
White House releases an update on the progress of the initiative to provide equitable access to COVID-19 testing and treatments in the US.
Twenty Percent of DME Suppliers Non-Compliant When Billing Medicare
OIG report finds that $8 million of $40 million in claims made by such suppliers in a recent audit did not meet Medicare requirements.
Does Offering Free Access to Drug Pricing Tool Cross the Kickback Line?
NY federal court ruling sheds light on what constitutes “remuneration” banned by the Anti-Kickback Statute.
Illumina and Precision Health Team Up for Population Study
Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.
New Senate Bill Targets PBM Consumer Abuses
Lawmakers blame pharmacy benefit managers for high drug prices, introducing a bill to prevent what they term unfair practices.